Menu
Back to Journals » ClinicoEconomics and Outcomes Research » Volume 10
Original Research
Clinical and economic impact of the 21-gene recurrence score assay in adjuvant therapy decision making in patients with early-stage breast cancer: pooled analysis in 4 Basque Country university hospitals
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 8,928 | Dovepress* | 8,428+ | 1,709 | 10,137 | |
| PubMed Central* | 500 | 154 | 654 | ||
| Totals | 8,928 | 1,863 | 10,791 | ||
| *Since 19 March 2018 | |||||
View citations on PubMed Central and Google Scholar